Ann-Christin Tallarek, Tanja Zeller, Alina Goßling, Caroline Kellner, Gudula Hansen, Mirja Pagenkemper, Charlotte Humke, Evelyn Annegret Huhn, Christopher Urbschat, Petra Clara Arck, Anke Diemert
{"title":"高敏感性CRP在超重和肥胖孕妇中升高,并受妊娠期体重增加的调节。","authors":"Ann-Christin Tallarek, Tanja Zeller, Alina Goßling, Caroline Kellner, Gudula Hansen, Mirja Pagenkemper, Charlotte Humke, Evelyn Annegret Huhn, Christopher Urbschat, Petra Clara Arck, Anke Diemert","doi":"10.1111/aogs.15135","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The global obesity epidemic presents a growing challenge in perinatal medicine and obstetrics, as it is associated with a higher risk of adverse maternal and perinatal outcomes. In addition to metabolic disturbances, obesity contributes to chronic low-grade inflammation. This study aims to investigate the relationship between maternal overweight, obesity, and excessive weight gain during pregnancy and high-sensitivity C-reactive protein (hs-CRP), an acute-phase reactant of inflammation and infection in maternal serum.</p><p><strong>Material and methods: </strong>The PRINCE (Prenatal Identification of Children's Health) study is a prospective longitudinal pregnancy cohort conducted at the University Medical Centre Hamburg-Eppendorf in Germany. In this study, biosamples and metadata were collected from 2011 to 2023. Hs-CRP levels were measured in each trimester among 582 healthy, low-risk women. Participants were categorized into weight classes based on their body mass index. Weight gain during pregnancy was evaluated according to the recommendations of the Institute of Medicine. For statistical analysis, the Wilcoxon and Kruskal-Wallis tests were employed for continuous variables, whereas the Mann-Whitney test was used for binary groups.</p><p><strong>Results: </strong>Hs-CRP levels are significantly higher in overweight and obese pregnant women throughout their pregnancy. During the first trimester, hs-CRP compared to those of normal-weight individuals (mean 3.4 mg/L; 95% CI 3.1 to 3.7) showed a 1.7-fold increase in overweight (mean 5.9 mg/L; 95% CI 5.0 to 6.7; p < 0.0001) and a 2.7-fold increase in obesity (mean 9.3 mg/L; 95% CI 7.6 to 11.0; p < 0.0001). Excessive weight gain during pregnancy is more common among overweight women (67%) and is associated with 1.5-fold heightened hs-CRP levels in the third trimester (mean 5.6 mg/L; 95% CI 4.7 to 6.4), compared to overweight women who follow the recommended weight gain guidelines (mean 3.7 mg/L; 95% CI 2.9 to 4.4; p = 0.009).</p><p><strong>Conclusions: </strong>Overweight and obesity, along with excessive gestational weight gain in individuals with preexisting overweight status, correlate with elevated levels of hs-CRP during pregnancy. This phenomenon indicates chronic low-grade inflammation in adipose tissue.</p>","PeriodicalId":6990,"journal":{"name":"Acta Obstetricia et Gynecologica Scandinavica","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"High-sensitivity CRP is elevated in pregnant women with overweight and obesity and modulated by gestational weight gain.\",\"authors\":\"Ann-Christin Tallarek, Tanja Zeller, Alina Goßling, Caroline Kellner, Gudula Hansen, Mirja Pagenkemper, Charlotte Humke, Evelyn Annegret Huhn, Christopher Urbschat, Petra Clara Arck, Anke Diemert\",\"doi\":\"10.1111/aogs.15135\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>The global obesity epidemic presents a growing challenge in perinatal medicine and obstetrics, as it is associated with a higher risk of adverse maternal and perinatal outcomes. In addition to metabolic disturbances, obesity contributes to chronic low-grade inflammation. This study aims to investigate the relationship between maternal overweight, obesity, and excessive weight gain during pregnancy and high-sensitivity C-reactive protein (hs-CRP), an acute-phase reactant of inflammation and infection in maternal serum.</p><p><strong>Material and methods: </strong>The PRINCE (Prenatal Identification of Children's Health) study is a prospective longitudinal pregnancy cohort conducted at the University Medical Centre Hamburg-Eppendorf in Germany. In this study, biosamples and metadata were collected from 2011 to 2023. Hs-CRP levels were measured in each trimester among 582 healthy, low-risk women. Participants were categorized into weight classes based on their body mass index. Weight gain during pregnancy was evaluated according to the recommendations of the Institute of Medicine. For statistical analysis, the Wilcoxon and Kruskal-Wallis tests were employed for continuous variables, whereas the Mann-Whitney test was used for binary groups.</p><p><strong>Results: </strong>Hs-CRP levels are significantly higher in overweight and obese pregnant women throughout their pregnancy. During the first trimester, hs-CRP compared to those of normal-weight individuals (mean 3.4 mg/L; 95% CI 3.1 to 3.7) showed a 1.7-fold increase in overweight (mean 5.9 mg/L; 95% CI 5.0 to 6.7; p < 0.0001) and a 2.7-fold increase in obesity (mean 9.3 mg/L; 95% CI 7.6 to 11.0; p < 0.0001). Excessive weight gain during pregnancy is more common among overweight women (67%) and is associated with 1.5-fold heightened hs-CRP levels in the third trimester (mean 5.6 mg/L; 95% CI 4.7 to 6.4), compared to overweight women who follow the recommended weight gain guidelines (mean 3.7 mg/L; 95% CI 2.9 to 4.4; p = 0.009).</p><p><strong>Conclusions: </strong>Overweight and obesity, along with excessive gestational weight gain in individuals with preexisting overweight status, correlate with elevated levels of hs-CRP during pregnancy. This phenomenon indicates chronic low-grade inflammation in adipose tissue.</p>\",\"PeriodicalId\":6990,\"journal\":{\"name\":\"Acta Obstetricia et Gynecologica Scandinavica\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-05-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Obstetricia et Gynecologica Scandinavica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/aogs.15135\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Obstetricia et Gynecologica Scandinavica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/aogs.15135","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
导言:全球肥胖流行对围产期医学和产科提出了越来越大的挑战,因为它与孕产妇和围产期不良结局的高风险相关。除了代谢紊乱,肥胖还会导致慢性低度炎症。本研究旨在探讨妊娠期孕妇超重、肥胖、体重过度增加与孕妇血清炎症感染急性期反应物高敏c反应蛋白(hs-CRP)的关系。材料和方法:PRINCE(产前儿童健康鉴定)研究是在德国汉堡-埃彭多夫大学医学中心进行的一项前瞻性纵向妊娠队列研究。在本研究中,从2011年到2023年收集了生物样本和元数据。在582名健康、低风险的妇女中,每个孕期测量Hs-CRP水平。参与者根据他们的身体质量指数被划分为不同的体重等级。怀孕期间的体重增加是根据医学研究所的建议进行评估的。在统计分析中,连续变量采用Wilcoxon检验和Kruskal-Wallis检验,二元组采用Mann-Whitney检验。结果:Hs-CRP水平在超重和肥胖孕妇的整个怀孕期间明显较高。在妊娠早期,hs-CRP与正常体重个体相比(平均3.4 mg/L;95% CI 3.1 - 3.7)显示超重增加1.7倍(平均5.9 mg/L;95% CI 5.0 ~ 6.7;p结论:超重和肥胖,以及先前存在超重状态的个体妊娠期体重过度增加,与妊娠期hs-CRP水平升高相关。这种现象表明脂肪组织存在慢性低度炎症。
High-sensitivity CRP is elevated in pregnant women with overweight and obesity and modulated by gestational weight gain.
Introduction: The global obesity epidemic presents a growing challenge in perinatal medicine and obstetrics, as it is associated with a higher risk of adverse maternal and perinatal outcomes. In addition to metabolic disturbances, obesity contributes to chronic low-grade inflammation. This study aims to investigate the relationship between maternal overweight, obesity, and excessive weight gain during pregnancy and high-sensitivity C-reactive protein (hs-CRP), an acute-phase reactant of inflammation and infection in maternal serum.
Material and methods: The PRINCE (Prenatal Identification of Children's Health) study is a prospective longitudinal pregnancy cohort conducted at the University Medical Centre Hamburg-Eppendorf in Germany. In this study, biosamples and metadata were collected from 2011 to 2023. Hs-CRP levels were measured in each trimester among 582 healthy, low-risk women. Participants were categorized into weight classes based on their body mass index. Weight gain during pregnancy was evaluated according to the recommendations of the Institute of Medicine. For statistical analysis, the Wilcoxon and Kruskal-Wallis tests were employed for continuous variables, whereas the Mann-Whitney test was used for binary groups.
Results: Hs-CRP levels are significantly higher in overweight and obese pregnant women throughout their pregnancy. During the first trimester, hs-CRP compared to those of normal-weight individuals (mean 3.4 mg/L; 95% CI 3.1 to 3.7) showed a 1.7-fold increase in overweight (mean 5.9 mg/L; 95% CI 5.0 to 6.7; p < 0.0001) and a 2.7-fold increase in obesity (mean 9.3 mg/L; 95% CI 7.6 to 11.0; p < 0.0001). Excessive weight gain during pregnancy is more common among overweight women (67%) and is associated with 1.5-fold heightened hs-CRP levels in the third trimester (mean 5.6 mg/L; 95% CI 4.7 to 6.4), compared to overweight women who follow the recommended weight gain guidelines (mean 3.7 mg/L; 95% CI 2.9 to 4.4; p = 0.009).
Conclusions: Overweight and obesity, along with excessive gestational weight gain in individuals with preexisting overweight status, correlate with elevated levels of hs-CRP during pregnancy. This phenomenon indicates chronic low-grade inflammation in adipose tissue.
期刊介绍:
Published monthly, Acta Obstetricia et Gynecologica Scandinavica is an international journal dedicated to providing the very latest information on the results of both clinical, basic and translational research work related to all aspects of women’s health from around the globe. The journal regularly publishes commentaries, reviews, and original articles on a wide variety of topics including: gynecology, pregnancy, birth, female urology, gynecologic oncology, fertility and reproductive biology.